Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Regulatory round-up: A month of key FDA approvals for cancer drugs

Four cancer drugs have got the FDA nod in May thus far, with approvals spanning haematological and solid tumour indications.

Latest news

Pfizer receives EC approval for Hympavzi to treat haemophilia

The approval covers all 27 EU member states, Liechtenstein, Norway, and Iceland.

Imfinzi set to become first immunotherapy for stomach cancer patients on NHS

AstraZeneca’s targeted treatment helps patients live longer, along with preventing cancer recurrence.

ECO 2026: gut hormone signals differ in T1D with obesity

While exploratory, the study adds to a growing body of evidence that obesity in T1D may not simply mirror obesity in type 2 diabetes (T2D) or the general population.

ECO 2026: REDEFINE-1 demonstrates CagriSema’s improvement in body composition

This analysis aimed to evaluate muscle strength, changes in body composition assessed by dual-energy DXA, and the correlation between body composition and physical function.

Zydus to acquire Assertio in $166m deal

The deal is expected to close in the second quarter of 2026, pending customary closing conditions.